Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.56 USD
Change Today -0.05 / -8.20%
Volume 47.7K
As of 11:07 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

biolargo inc (BLGO) Snapshot

Open
$0.61
Previous Close
$0.61
Day High
$0.65
Day Low
$0.56
52 Week High
09/1/15 - $0.75
52 Week Low
06/9/15 - $0.22
Market Cap
47.3M
Average Volume 10 Days
46.9K
EPS TTM
$-0.05
Shares Outstanding
84.5M
EX-Date
09/2/97
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOLARGO INC (BLGO)

Related News

No related news articles were found.

biolargo inc (BLGO) Related Businessweek News

No Related Businessweek News Found

biolargo inc (BLGO) Details

BioLargo, Inc. designs and delivers nature’s disinfectant iodine. Its technologies include AOS Filter, CupriDyne, and Isan system. The company offers its products to various problems, such as disinfection, unsurpassed odor and moisture control, and wound healing. It markets its products under the Odor-No-More, Nature’s Best Solution, Deodorall, and NBS brand names primarily through retail stores. The company serves food processing, agriculture, and oil and gas industries. BioLargo, Inc. was founded in 1989 and is based in Santa Ana, California.

9 Employees
Last Reported Date: 03/31/15
Founded in 1989

biolargo inc (BLGO) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $288.6K
Chief Financial Officer and Principal Account...
Total Annual Compensation: --
Executive Vice President, Vice President of O...
Total Annual Compensation: $147.3K
Chief Science Officer and Director
Total Annual Compensation: $288.6K
Compensation as of Fiscal Year 2014.

biolargo inc (BLGO) Key Developments

BioLargo Eyes Acquisitions

BioLargo, Inc. (OTCPK:BLGO) is looking for acquisitions. The company said, "We will be required to raise substantial additional capital to expand our operations, including without limitation, hiring additional personnel, additional scientific and third-party testing, costs associated with obtaining regulatory approvals and filing additional patent applications to protect our intellectual property, and possible strategic acquisitions or alliances, as well as to meet our liabilities as they become due for the next 12 months."

BioLargo, Inc., Annual General Meeting, Jun 24, 2015

BioLargo, Inc., Annual General Meeting, Jun 24, 2015., at 10:00 Pacific Standard Time. Location: 3500 W. Garry Avenue. Agenda: To elect the following seven individuals to Board of Directors: Dennis P. Calvert, Kenneth R. Code, Gary A. Cox, Dennis E. Marshall, Joseph L. Provenzano, Kent C. Roberts II, and John S. Runyan; to consider advisory approval of the company's executive compensation; to ratify the appointment of Haskell & White LLP as independent public accounting firm for the 2015 fiscal year; and to consider such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.

BioLargo, Inc. Presents at 2nd Annual Growth Capital Expo, Apr-13-2015

BioLargo, Inc. Presents at 2nd Annual Growth Capital Expo, Apr-13-2015 . Venue: Caesars Palace, Las Vegas, Nevada, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLGO:US $0.56 USD -0.05

BLGO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Church & Dwight Co Inc $84.69 USD +0.77
Derma Sciences Inc $5.78 USD +0.04
Smith & Nephew PLC 1,136 GBp +6.00
STERIS Corp $62.67 USD +0.36
View Industry Companies
 

Industry Analysis

BLGO

Industry Average

Valuation BLGO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 231.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 232.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOLARGO INC, please visit www.biolargo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.